Macbeth, Fergus, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Evans, Jessica, Ahmed, Sheikh, Cohen, David, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Knoyle, Dana, Linnane, Seamus, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Moore, Barbara, Woll, Penella J., Appel, Wiebke, Dickson, Jeanette, Ferry, David, Brammer, Caroline and Griffiths, Gareth 2016. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial. Journal of Clinical Oncology 34 (5) , pp. 488-494. 10.1200/JCO.2015.64.0268 |
Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003 |